Acute Bacterial Skin and Skin Structure Infections Global Market Report 2024 – Market Size, Trends, And Forecast 2024-2033

LONDON, GREATER LONDON, UK, July 29, 2024 /EINPresswire.com/ -- The global acute bacterial skin and skin structure infections market is projected to expand from $10.57 billion in 2023 to $11.75 billion in 2024, reflecting a compound annual growth rate (CAGR) of 11.2%. Despite ongoing challenges such as antibiotic resistance and evolving treatment protocols, the market is anticipated to reach $17.17 billion by 2028 at a CAGR of 9.9%, driven by the increasing prevalence of chronic diseases and advancements in diagnostic and therapeutic approaches.

Rising Prevalence of Chronic Diseases Fuels Market Growth
The growth of the acute bacterial skin and skin structure infections market is significantly influenced by the increasing prevalence of chronic diseases. Chronic conditions, which often lead to prolonged and recurrent bacterial infections, are elevating the demand for effective treatments. According to the World Health Organization, chronic diseases are responsible for a significant number of global deaths annually, highlighting the need for continued innovation and effective management in this field.

Explore comprehensive insights into the global acute bacterial skin and skin structure infections market with a detailed sample report:
https://www.thebusinessresearchcompany.com/sample_request?id=13282&type=smp

Major Players and Market Innovations
Key players such as Pfizer Inc., AbbVie Inc., and Novartis AG are spearheading advancements with innovative therapies. A notable development is the launch of Dalbonova Injection by BDR Pharmaceuticals Internationals Pvt. Ltd. in August 2023. This single-dose therapy simplifies treatment for acute bacterial skin and skin structure infections, reducing hospital admissions and improving patient convenience.

Trends Shaping the Market
Several trends are shaping the acute bacterial skin and skin structure infections market:
• Antibiotic Resistance Concerns: Growing resistance to antibiotics is driving the need for new treatment strategies.
• Advancements in Treatment Strategies: Innovation in therapies is improving efficacy and patient outcomes.
• Focus on Outpatient Treatment: There is a shift towards outpatient care, facilitated by new, effective treatments.

Segments
• Type of Infection: Hospital-acquired Acute Bacterial Skin and Skin Structure Infections, Community-acquired Acute Bacterial Skin and Skin Structure Infections
• Active Ingredients: Delafloxacin, Vancomycin, Ceftaroline fosamil, Oritavancin, Tedizolid, Daptomycin, Tigecycline, Linezolid, Other Active Ingredients
• Route of Administration: Oral, Parenteral, Topical
• Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
• Application: Cellulitis, Abscess, Surgical Wounds, Traumatic Wound

Regional Insights: Asia-Pacific Leading the Market
Asia-Pacific emerged as the largest region in the acute bacterial skin and skin structure infections market in 2023. Looking forward, North America is expected to be the fastest-growing region, driven by advancements in healthcare infrastructure and increasing healthcare expenditures.

Explore the report store to make a direct purchase of the report
https://www.thebusinessresearchcompany.com/report/acute-bacterial-skin-and-skin-structure-infections-global-market-report

Acute Bacterial Skin And Skin Structure Infections Global Market Report 2024 from TBRC covers the following information:
• Market size data for the forecast period: Historical and Future
• Market analysis by region: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.
• Market analysis by countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Trends, opportunities, strategies and so much more.
The Acute Bacterial Skin And Skin Structure Infections Global Market Report 2024 by The Business Research Company is the most comprehensive report that provides insights on acute bacterial skin and skin structure infections market size, acute bacterial skin and skin structure infections market drivers and trends, acute bacterial skin and skin structure infections market major players, competitors' revenues, market positioning, and market growth across geographies. The acute bacterial skin and skin structure infections market report helps you gain in-depth insights on opportunities and strategies. Companies can leverage the data in the report and tap into segments with the highest growth potential.

Browse Through More Similar Reports By The Business Research Company:

Antibacterial Products Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/antibacterial-products-global-market-report

Skin And Hide Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/skin-and-hide-global-market-report

Skin Care Products Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/skin-care-products-global-market-report

About The Business Research Company?
The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Global Market Model – Market Intelligence Database
The Global Market Model, The Business Research Company’s flagship product, is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets that help its users assess supply-demand gaps.

Contact Information
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
info@tbrc.info
Visit us on social media:
Facebook
X
LinkedIn